Project Grant K23HL168331
Award Date 9/22/25
Completion Date 8/31/30
Dollars Obligated $186K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $472,621 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to Duke University in North Carolina. The goal of this 1-year project is to conduct a randomized, controlled trial to evaluate the impact of a multi-component lifestyle intervention, including dietary changes, increased physical activity, and weight management, on improving blood pressure control in Black adults with chronic kidney disease (CKD). This...
- The Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support the co-development of a stress management intervention for Black adults with hypertension. The $169,444 award to the Trustees of Indiana University, Indianapolis will fund a 5-year project to iteratively design and pilot test a stress management intervention tailored for this high-risk population. The intervention aims to reduce stress...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $169,992 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to the University of Colorado-Denver. The grant, titled "START STRONG: A MIXED METHODS STUDY TO INFORM INITIAL ANTIHYPERTENSIVE PRESCRIBING AND A PATIENT-SELF TITRATION INTERVENTION TO IMPROVE BLOOD PRESSURE CONTROL, SAFETY, AND REDUCE CARDIOVASCULAR RISK", aims to understand barriers and facilitators to initiating antihypertensive combination...
- This $101,360 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support Dr. Andrew Davis' research to develop expertise in clinical epidemiology, causal inference, and informatics. The goal is for Dr. Davis to ultimately become an independent health services researcher investigating evidence-based interventions to improve outcomes for survivors of pneumonia and respiratory failure. The...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to understand disparities in the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The $502,069 award to Mayo Clinic, a non-profit academic medical center, will quantify the moderating effect of socioeconomic status (SES) on the relationship between urban/rural status and HDP. The research...
- This $173,352 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support a research project titled "Molecular Characterization of Frailty and Functional Limitations in HFPEF" at Vanderbilt University Medical Center (VUMC). The project aims to investigate the association between the human proteome and multi-organ dysfunction in heart failure with preserved ejection fraction (HFPEF), as well as identify...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to investigate how hypertension leads to "trained immunity" in myeloid cells, which may contribute to increased inflammation and atherosclerosis. The $786,060 grant awarded on May 1, 2025 is being conducted by the Vanderbilt University Medical Center to pursue this novel concept. Key activities include transplanting hypertension-associated...
- This $142,870 Project Grant, awarded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), aims to investigate inequities in end-of-life care for adults with heart failure. The project, titled "Dying While Poor: Investigating Multi-Level Determinants of Inequities in End-of-Life Care for Adults with Heart Failure," will use a mixed-methods approach to characterize the influence of individual, hospital, and neighborhood-level factors on...
- This Project Grant award of $201,426 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support a 5-year Training Program in Patient-Oriented Research in Cardiovascular Endocrinology at Brigham & Women's Hospital, a subsidiary of Partners Healthcare System. The program aims to address the decline in clinical investigators in patient-oriented research by providing comprehensive, curriculum-based and mentor-supported training for the next...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to discover novel biomarkers and biological mechanisms underlying early-stage heart failure (HF). The $147,486 award to Duke University will fund the development and validation of an automated computable phenotype to identify early-stage HF using clinical data and imaging. This work aims to better understand how early-stage HF differs from underlying risk...